Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 03/26/2018. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-3795-01
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)
- Initial Posting
- 03/26/2018
- Revised Date
Reason
Other